celltrion产品代理

A leading   force in the Korean pharmaceutical industry, Celltrion achieved what was   thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical   sector. The company has pioneered numerous uncharted areas to stellar   success, which it plans to follow up by continuing its growth as a global   biopharmaceutical company with unique approaches to small molecule   pharmaceuticals and new businesses such as the Ubiquitous-healthcare platform   business.

We aim to become a global pharmaceutical company that promotes health and welfare for all by developing next-generation biopharmaceutical and small molecule pharmaceutical products.